Intérêt du captopril dans le traitement d'une hypertension artérielle systémique et pulmonaire avec activité rénine plasmatique augmentée au cours d'une sclérodermie
- 30 June 1983
- journal article
- case report
- Published by Elsevier in La Revue de Médecine Interne
- Vol. 4 (2) , 125-129
- https://doi.org/10.1016/s0248-8663(83)80004-6
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Deleterious Effects of Hydralazine in Patients with Pulmonary HypertensionNew England Journal of Medicine, 1982
- Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor.Circulation, 1980
- Effects of the converting enzyme inhibitor (SQ 20881) on the pulmonary circulation in manThe American Journal of Medicine, 1979
- Reversal of Vascular and Renal Crises of Scleroderma by Oral Angiotensin-Converting-Enzyme BlockadeNew England Journal of Medicine, 1979
- Control of Hypertension and Reversal of Renal Failure in SclerodermaNew England Journal of Medicine, 1978
- The management of renal sclerodermaThe American Journal of Medicine, 1978
- Is Elevated Plasma Renin Activity of Prognostic Importance in Progressive Systemic Sclerosis?Archives of internal medicine (1960), 1977
- Pulmonary Hypertension in the CREST Syndrome Variant of Progressive Systemic Sclerosis (Scleroderma)Annals of Internal Medicine, 1977
- An Angiotensin Converting-Enzyme Inhibitor to Identify and Treat Vasoconstrictor and Volume Factors in Hypertensive PatientsNew England Journal of Medicine, 1974
- ACUTE RENAL FAILURE, TUBULAR NECROSIS, AND MYOCARDIAL INFARCTION INDUCED IN THE RABBIT BY INTRAVENOUS ANGIOTENSIN IIThe Lancet, 1971